Noble Life Sciences Granted Renewal of Full AAALAC Accreditation Status

2018-04-23T15:28:12-05:00July 17th, 2017|News|

NOBLE LIFE SCIENCES GRANTED RENEWAL OF FULL AAALAC ACCREDITATION STATUS Noble Life Sciences granted renewal of full AAALAC accreditation statusSykesville, MD; July 17, 2017 – Noble Life Sciences, a contract research organization (CRO) providing services to support the development of drugs, vaccines, and medical devices, is pleased to announce that it has been granted a renewal of full accreditation by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International Council on Accreditation. Noble was first awarded AAALAC full accreditation in October 10, 1989.The renewal, which was granted after an extensive on-site assessment and review of the Noble [...]

Noble Life Sciences Names Srujana Cherukuri CEO

2018-04-23T15:26:36-05:00April 24th, 2017|News|

NOBLE LIFE SCIENCES NAMES SRUJANA CHERUKURI CEO SYKESVILLE, MD – April 24, 2017 – Noble Life Sciences, a full service, GLP (Good Laboratory Practice)-compliant and non-GLP preclinical contract research organization (CRO), today announced that its Board of Directors has appointed Srujana Cherukuri as Chief Executive Officer (CEO) effective immediately. The board also announced that Dr. Cherukuri is now majority owner of Noble Life Sciences. "With the acquisition of Spring Valley Laboratories, Noble Life Sciences has grown from a contract research organization offering in vivo drug services in small animals to a full service CRO offering services for the development of drugs, devices, [...]

Noble Life Sciences Consolidates Operations at Spring Valley Laboratories Site

2018-04-23T15:21:54-05:00February 29th, 2016|News|

NOBLE LIFE SCIENCES CONSOLIDATES OPERATIONS AT SPRING VALLEY LABORATORIES' SITE Noble Life Sciences Consolidates Operations at Spring Valley Laboratories’ Site-       Closes Facility in Montgomery County MarylandSykesville, MD; February  29, 2016 – Noble Life Sciences (Sykesville, MD), a full service, Good Laboratory Practice (GLP) and non-GLP preclinical contract research organization (CRO), today announced the completion of the consolidation of their operations at the Spring Valley Laboratories site in Sykesville, Maryland. The company will provide all services, both GLP and non-GLP, at the site and has closed the Montgomery County facility.  The consolidation of operations is a major step in the integration [...]

Noble Life Sciences Acquires Spring Valley Laboratories Extends Testing Services to GLP Large Animal and Medical Device Studies

2018-04-23T15:20:59-05:00December 3rd, 2014|News|

NOBLE LIFE SCIENCES ACQUIRES SPRING VALLEY LABORATORIES EXTENDS TESTING SERVICES TO GLP, LARGE ANIMAL AND MEDICAL DEVICE STUDIES Gaithersburg, MD; December 3, 2014 – Noble Life Sciences (Gaithersburg, MD), a provider of preclinical drug development services, today announced the acquisition of Spring Valley Laboratories (Sykesville, MD), a full service, GLP (Good Laboratory Practice)-compliant, preclinical contract research organization (CRO) for the development of drugs, vaccines, and medical devices.   The acquisition greatly expands Noble’s services to include GLP regulatory standards, studies in small and large animals, and testing capabilities for vaccines and medical devices. Combined with Noble’s recognized strength conducting [...]

Cotton Rat Influenza Model Launched by Noble Life Sciences in Partnership with IBT Bioservices

2018-05-24T11:00:09-05:00April 22nd, 2014|News|

COTTON RAT INFLUENZA MODEL LAUNCHED BY NOBLE LIFE SCIENCES IN PARTNERSHIP WITH IBT BIOSERVICES Gaithersburg, MD; April 22, 2014 – Noble Life Sciences (Gaithersburg, MD) and IBT Bioservices (Gaithersburg, MD) announce a newly optimized cotton rat model for preclinical studies of influenza therapies and vaccines. The companies jointly developed the model of influenza infection in the cotton rat.   Cotton rats are a vital tool to study influenza infection because adaptation of human influenza strains is not required for virus replication in the respiratory tract.  Moreover, virus infection results in histopathological lesions in the lungs that are similar to [...]

Cotton Rat RSV Model Launched By Noble Life Sciences in Partnership with IBT Bioservices

2018-05-24T10:59:21-05:00January 29th, 2014|News|

COTTON RAT RSV MODEL LAUNCHED BY NOBLE LIFE SCIENCES IN PARTNERSHIP WITH IBT BIOSERVICES Gaithersburg, MD; January 28, 2014 – Noble Life Sciences (Gaithersburg, MD), in collaboration with IBT Bioservices (Gaithersburg, MD), announces a newly optimized cotton rat model for preclinical studies of RSV (respiratory syncytial virus) therapies and vaccines. The companies jointly developed the model of RSV infection in the cotton rat and demonstrated its use to evaluate the efficacy of test compounds in RSV challenge studies.    Cotton rats are the gold standard for preclinical development of drugs and vaccines for RSV.  The cotton rat gained importance [...]

Noble Life Sciences Receives Maryland Tedco Award for Development of ex Vivo and in Vivo Assays for Anti Metastatic Drug Development

2018-04-23T15:17:39-05:00December 5th, 2013|News|

NOBLE LIFE SCIENCES RECEIVES MARYLAND TEDCO AWARD FOR DEVELOPMENT OF EX VIVO AND IN VIVO ASSAYS FOR ANTI-METASTATIC DRUG DEVELOPMENT Gaithersburg, MD; December 4, 2013 – Noble Life Sciences (Gaithersburg, MD) announced today that the company has been awarded a Technology Commercialization Fund (TCF) grant of $100,000 from the Maryland Technology Development Corporation (TEDCO). The grant will be used to develop assays to determine the effect of cancer treatments on metastatic cells derived directly from patients. Metastasis-initiating tumor cells isolated from the blood of cancer patients will be used to assay the activity of drugs both in culture [...]

Noble Life Sciences Animal Facility Awarded Full AAALAC Accreditation

2018-04-23T15:16:27-05:00October 30th, 2013|News|

NOBLE LIFE SCIENCES ANIMAL FACILITY AWARDED FULL AAALAC ACCREDITATION Gaithersburg, MD; October 30, 2013 – Noble Life Sciences, a provider of preclinical research services to pharmaceutical and biotechnology companies, announced today that its animal facility was awarded full accreditation by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC International). AAALAC assessment and accreditation programs are designed to recognize organizations that demonstrate excellence in animal care and use.Organizations volunteer to participate in AAALAC's program in addition to complying with local, state and federal laws that regulate use of animals in research. Accreditation was awarded following submission [...]

Neutropenic Mouse Thigh Model Now Offered by Noble Life Sciences

2018-04-23T15:15:11-05:00October 7th, 2013|News|

NEUTROPENIC MOUSE THIGH MODEL NOW OFFERED BY NOBLE LIFE SCIENCES Neutropenic Mouse Thigh Model Now Offered by Noble Life SciencesGaithersburg, MD; October 7, 2013 – Noble Life Sciences (Gaithersburg, MD), in collaboration with ImQuest BioSciences (Frederick, MD), has successfully developed a neutropenic mouse thigh model of infection and demonstrated its use in a study evaluating vancomycin for the treatment of Staphylococcus aureus infection. The model will serve as a new Noble service for the evaluation of the efficacy of novel anti-microbial compounds in the treatment of microbial infections.Complicated skin and soft tissue infections are frequently encountered in clinical practice and [...]